Document Classification

Section Type: METHODS

Text: A total of 602 patients were randomly assigned to one of four regimens : cisplatin 80 mg/m (2) on day 1 plus irinotecan 60 mg/m (2) on days 1, 8, 15 every 4 weeks (IP) carboplatin AUC 6. 0 min x mg/mL (area under the concentration-time curve) on day 1 plus paclitaxel 200 mg/m (2) on day 1 every 3 weeks (TC) ; cisplatin 80 mg/m (2) on day 1 plus gemcitabine 1000 mg/m (2) on days 1, 8 every 3 weeks (GP) ; and cisplatin 80 mg/m (2) on day 1 plus vinorelbine 25 mg/m (2) on days 1, 8 every 3 weeks (NP).